SCHEMBL2799752

SCHEMBL2799752

N=C1C=C(N(N)N)C(=O)c2ccccc21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC2A1 P11166 1/20 0.56
▸ S100A4 P26447 3/20 0.42
▸ MEN1 O00255 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ CDC25B P30305 2/20 0.41
▸ MAPT P10636 6/20 0.39
▸ SMN1; SMN2 Q16637 5/20 0.39
▸ MAPK1 P28482 5/20 0.39
▸ NPC1 O15118 5/20 0.39
▸ RAB9A P51151 5/20 0.39
▸ MAOA P21397 4/20 0.39
▸ HTT P42858 2/20 0.39
▸ APAF1 O14727 2/20 0.39
▸ TDP2 O95551 2/20 0.39
▸ CES1 P23141 2/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ PLIN1 O60240 2/20 0.39
▸ LMNA P02545 2/20 0.39
▸ POLB P06746 2/20 0.39
▸ PTPRC P08575 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3273421 0.74 SLC2A1 (0.96) SLC2A1S100A4MEN1KMT2ACDC25B
Hydrochloric Acid SCHEMBL29365758 0.72 SLC2A1 (1.00) SLC2A1S100A4MEN1KMT2ACDC25B
Hydrochloric Acid SCHEMBL3343803 0.72 SLC2A1 (1.00) SLC2A1S100A4MEN1KMT2ACDC25B
SCHEMBL7997569 0.69 SLC2A1 (0.57) SLC2A1S100A4MEN1KMT2ACDC25B
Anthraquinone SCHEMBL25230500 0.63 MEN1 (0.86) S100A4MEN1KMT2ACDC25BMAPT
SCHEMBL23422731 0.63 SLC2A1 (0.48) SLC2A1S100A4MEN1KMT2ACDC25B
Anthraquinone SCHEMBL14943 0.62 MEN1 (1.00) S100A4MEN1KMT2ACDC25BMAPT
Anthraquinone SCHEMBL29358690 0.62 MEN1 (1.00) S100A4MEN1KMT2ACDC25BMAPT
Anthraquinone SCHEMBL1901249 0.62 MEN1 (1.00) S100A4MEN1KMT2ACDC25BMAPT
SCHEMBL1477146 0.62 S100A4 (0.75) SLC2A1S100A4MEN1KMT2ACDC25B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8598146-B2 Methods for identifying modulators of protein kinase C-epsilon (PKCε) and method of treatment of aberrant glucose metabolism associated therewith GARVAN INSTITUTE OF MEDICAL RESEARCH (AU) 2013-12-03 — — US disclosed
EP-2228069-A1 Antagonists of protein kinase c-epsilon (pkcepsilon) and their use for the treatment of aberrant glucose metabolism associated therewith. GARVAN INSTITUTE OF MEDICAL RESEARCH (AU) 2010-09-15 — — EP disclosed
US-20080263689-A1 Screening/monitoring rate of internalization of insulin receptors in insulin-stimulated hepatocytes; identifying modulators of insulin clearance and secretion; treating insulin resistance GARVAN INSTITUTE OF MEDICAL RESEARCH (AU) 2008-10-23 — — US disclosed
Send feedback